tradmap

BTMD biote Corp.

$1.54 -9.91%

Updated

Healthcare · Medicinal Chemicals & Botanical Products

biote Corp. (BTMD) is a healthcare company in the Medicinal Chemicals & Botanical Products industry, with a market capitalization of $46 million. Shares last traded at $1.54, 56.8% below their 52-week high. Over the past year the stock is down 55.7%. BTMD trades at a price-to-earnings ratio of 7.82, below the Medicinal Chemicals & Botanical Products median of 14.86. Net profit margin is 3.2%, above the peer median of -8.5%. Revenue declined 2.5% year over year.

Market Cap
$46M
Shares Out
29.6M
EPS (TTM)
$1.06
P/E Ratio
1.46
P/S Ratio
0.25
P/B Ratio
Dividend / Share
Dividend Yield
52-Week High
$3.58
52-Week Low
$1.27
Volume
8,419
Avg Vol (3m)
16,299.794

Performance

1W
-5.21%
1M
-29.77%
3M
-35.08%
6M
-25.36%
YTD
-37.95%
1Y
-55.73%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
42.41
SMA (50)
$1.92
SMA (200)
$2.11
Price vs SMA50
-19.72%
Price vs SMA200
-26.62%
ATR (14)
$0.14

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$184M
Net Income
$6M
Gross Margin
Operating Margin
8.0%
Net Margin
3.2%
Return on Equity
-8.9%
Return on Assets
5.8%
Current Ratio
1.43
Debt / Equity
-1.90
Revenue Growth (YoY)
-2.5%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

BTMD Dividend History

Payout ratio (latest FY)
6%
Fiscal year endTotal dividends paidPer share*Payout ratio
2025-12-31 $2M $0.05 6%
2024-12-31 $5M $0.14 150%
2023-12-31 $9M $0.34 262%
2022-12-31 $13M $0.00
2021-12-31 $11M 103%

*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.

Compare payers on the highest-dividend-yield screener.

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-0.14 2026-08-07
Q1 2026 $0.06 2026-05-11
FY 2025 $0.74 2026-03-13
Q3 2025 $0.68 2025-11-07
Q2 2026 $0.46 2026-08-07
Q1 2026 $0.37 2026-05-11

Full earnings history →

Medicinal Chemicals & Botanical Products peers

BTMD vs 14 industry peers (Medicinal Chemicals & Botanical Products), by market cap. Updated

P/E vs peers
7.82 / 14.86 med
-47% discount
P/S vs peers
0.25 / 0.29 med
-15% discount
Net margin vs peers
3.2% / -8.5% med
above median
1–14 of 14
DFTXDefinium Therapeutics, Inc.$5.1B-14.43-2.40%
TRLVTrulieve Cannabis Corp.$2.3B-4.862.03-41.8%+2.56%
TLRYTilray Brands$616M-5.070.67-13.3%+0.11%
USNAUSANA HEALTH SCIENCES INC$267M-12.030.29-2.4%-1.30%
NAGENiagen Bioscience, Inc.$246M15.411.9112.4%-1.89%
FTLFFITLIFE BRANDS, INC.$93M14.860.916.2%-3.10%
BTMDbiote Corp.$46M7.820.253.2%-9.91%
MTEXMANNATECH INC$14M-1.900.13-6.9%-2.93%
NAIINATURAL ALTERNATIVES INTERNATIONAL INC$12M-0.860.09-10.1%-0.47%
SNYRSynergy CHC Corp.$2M-0.100.06-57.0%-2.03%
CRONCronos Group39.1%+0.46%
CGCCanopy Growth-80.4%+0.27%
GLASGlass House Brands Inc.-16.3%+3.61%
IMCCIM Cannabis Corp.-27.57%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.